Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)
Clinical trial NCT02622724 · TERMINATED
Trial details
- NCT number
- NCT02622724
- Sponsor
- Faron Pharmaceuticals Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-23
- Primary completion
- 2018-05-17
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.